PortfoliosLab logoPortfoliosLab logo
SIFY vs. AMLX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SIFY vs. AMLX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sify Technologies Limited (SIFY) and Amylyx Pharmaceuticals, Inc. (AMLX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SIFY achieves a 27.07% return, which is significantly lower than AMLX's 34.77% return.


SIFY

1D
1.91%
1M
-4.03%
YTD
27.07%
6M
30.28%
1Y
263.62%
3Y*
11.95%
5Y*
-7.05%
10Y*
9.80%

AMLX

1D
3.89%
1M
19.88%
YTD
34.77%
6M
30.24%
1Y
222.38%
3Y*
-10.96%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SIFY vs. AMLX - Yearly Performance Comparison


2026 (YTD)2025202420232022
SIFY
Sify Technologies Limited
27.07%326.22%-74.44%61.96%-62.12%
AMLX
Amylyx Pharmaceuticals, Inc.
34.77%219.58%-74.32%-60.16%75.95%

Correlation

The correlation between SIFY and AMLX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.11

Correlation (All Time)
Calculated using the full available price history since Jan 7, 2022

0.15

Fundamentals

Market Cap

SIFY:

$963.39M

AMLX:

$1.80B

EPS

SIFY:

-₹25.24

AMLX:

-$1.55

PB Ratio

SIFY:

4.65

AMLX:

6.59

Total Revenue (TTM)

SIFY:

₹42.55B

AMLX:

$0.00

Gross Profit (TTM)

SIFY:

₹15.05B

AMLX:

-$20.10M

EBITDA (TTM)

SIFY:

₹7.93B

AMLX:

-$150.30M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SIFY vs. AMLX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SIFY
SIFY Risk / Return Rank: 9393
Overall Rank
SIFY Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
SIFY Sortino Ratio Rank: 9292
Sortino Ratio Rank
SIFY Omega Ratio Rank: 9191
Omega Ratio Rank
SIFY Calmar Ratio Rank: 9595
Calmar Ratio Rank
SIFY Martin Ratio Rank: 9393
Martin Ratio Rank

AMLX
AMLX Risk / Return Rank: 9494
Overall Rank
AMLX Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
AMLX Sortino Ratio Rank: 9595
Sortino Ratio Rank
AMLX Omega Ratio Rank: 9191
Omega Ratio Rank
AMLX Calmar Ratio Rank: 9696
Calmar Ratio Rank
AMLX Martin Ratio Rank: 9494
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SIFY vs. AMLX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sify Technologies Limited (SIFY) and Amylyx Pharmaceuticals, Inc. (AMLX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SIFYAMLXDifference
Sharpe ratioReturn per unit of total volatility

+0.07

Sortino ratioReturn per unit of downside risk

-0.51

Omega ratioGain probability vs. loss probability

1.44

1.44

0.00

Calmar ratioReturn relative to maximum drawdown

6.60

7.31

-0.71

Martin ratioReturn relative to average drawdown

14.06

15.68

-1.62

SIFY vs. AMLX - Sharpe Ratio Comparison

The current SIFY Sharpe Ratio is 3.40, which is comparable to the AMLX Sharpe Ratio of 3.33. The chart below compares the historical Sharpe Ratios of SIFY and AMLX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

SIFY vs. AMLX - Drawdown Comparison

The maximum SIFY drawdown since its inception was -99.59%, roughly equal to the maximum AMLX drawdown of -96.04%. Use the drawdown chart below to compare losses from any high point for SIFY and AMLX.


Loading charts...

Drawdown Indicators


SIFYAMLXDifference

Max Drawdown

Largest peak-to-trough decline

-99.59%

-96.04%

-3.55%

Max Drawdown (1Y)

Largest decline over 1 year

-40.23%

-30.61%

-9.62%

Max Drawdown (3Y)

Largest decline over 3 years

-89.64%

-93.09%

+3.45%

Max Drawdown (5Y)

Largest decline over 5 years

-91.98%

Max Drawdown (10Y)

Largest decline over 10 years

-94.34%

Current Drawdown

Current decline from peak

-54.31%

-60.22%

+5.91%

Average Drawdown

Average peak-to-trough decline

-79.25%

-59.40%

-19.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.84%

14.25%

+4.59%

Volatility

SIFY vs. AMLX - Volatility Comparison

Sify Technologies Limited (SIFY) has a higher volatility of 23.96% compared to Amylyx Pharmaceuticals, Inc. (AMLX) at 16.44%. This indicates that SIFY's price experiences larger fluctuations and is considered to be riskier than AMLX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SIFYAMLXDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.96%

16.44%

+7.52%

Volatility (6M)

Calculated over the trailing 6-month period

45.90%

43.21%

+2.69%

Volatility (1Y)

Calculated over the trailing 1-year period

78.15%

67.39%

+10.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

88.52%

91.47%

-2.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.55%

91.47%

-6.92%

Dividends

SIFY vs. AMLX - Dividend Comparison

Neither SIFY nor AMLX has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
AMLX
Amylyx Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SIFY
Sify Technologies Limited
0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.11%0.96%0.83%136.99%101.52%

Financials

SIFY vs. AMLX - Financials Comparison

This section allows you to compare key financial metrics between Sify Technologies Limited and Amylyx Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B10.00B12.00B20222023202420252026
11.60B
0
(SIFY) Total Revenue
(AMLX) Total Revenue
Please note, different currencies. SIFY values in INR, AMLX values in USD

Frequently Asked Questions


SIFY and AMLX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SIFY has higher volatility (23.96%) compared to AMLX (16.44%). In terms of maximum drawdown, SIFY dropped -99.59% vs AMLX's -96.04%.

SIFY currently has the higher Sharpe Ratio (3.40 vs 3.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SIFY and AMLX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer